News and Trends 10 Aug 2015
Evotec enters Immuno-Oncology and Diabetes Therapy with Help from Sanofi
Evotec had to announce a setback recently when its Alzheimer’s treatment in collaboration with Roche failed in Phase IIb. However, another strong partner on its side, Sanofi, never lost trust in the German biotech’s value. In the last three days, the French giant entered into two new projects with Evotec, which target diabetes and immuno-oncology. […]